{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:26:16Z","timestamp":1785374776277,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.urolonc.2020.12.007","type":"journal-article","created":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T06:54:42Z","timestamp":1609484082000},"page":"286-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer"],"prefix":"10.1016","volume":"39","author":[{"given":"Timothy D.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.12.007_bib0001","author":"Moch","year":"2016","journal-title":"WHO classification of tumours of the urinary system and male genital organs"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0002","series-title":"Bladder pathology","author":"Cheng","year":"2012"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0003","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.urolonc.2019.10.002","article-title":"Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?","volume":"38","author":"Hentschel","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0004","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/his.14192","article-title":"Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP)","volume":"77","author":"Jones","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0005","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.humpath.2012.01.008","article-title":"Histologic grading of urothelial carcinoma: A reappraisal","volume":"43","author":"Cheng","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0006","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00428-011-1072-3","article-title":"Histologic grading of urothelial papillary neoplasms: Impact of combined grading (two-numbered grading system) on reproducibility","volume":"458","author":"Tuna","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0007","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00428-003-0905-0","article-title":"Reproducibility of the 1998 World Health Organization\/International Society of Urologic Pathology classification of papillary urothelial neoplasms of the urinary bladder","volume":"443","author":"Yorukoglu","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0008","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1016\/j.clgc.2018.05.002","article-title":"Reproducibility and prognostic performance of the 1973 and 2004 World Health Organization Classifications for grade in non-muscle-invasive bladder cancer: A multicenter study in 328 bladder tumors","volume":"16","author":"Bosschieter","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0009","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)66443-9","article-title":"Stage progression in Ta papillary urothelial tumors: Relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy","volume":"165","author":"Holmang","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0010","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1309\/AJCP12MRVVHTCKEJ","article-title":"Prognostic significance of the 2004 WHO\/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: A clinicopathologic study of 1,515 cases","volume":"133","author":"Pan","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0011","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0012","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0013","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder cancer, Version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0014","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.euf.2018.11.005","article-title":"Risk stratification tools and prognostic models in non-muscle-invasive bladder Cancer: a critical sssessment from the European Association of Urology non-muscle-invasive bladder cancer guidelines panel","volume":"6","author":"Soukup","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humpath.2020.01.004","article-title":"The applicability and utility of immunohistochemical biomarkers in bladder pathology","volume":"98","author":"Akgul","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.humpath.2010.07.007","article-title":"Bladder cancer: Translating molecular genetic insights into clinical practice","volume":"42","author":"Cheng","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0017","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0018","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/14737159.2020.1699791","article-title":"Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers","volume":"20","author":"Lopez-Beltran","year":"2020","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0019","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/PAS.0000000000001453","article-title":"Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers. II. Molecular pathology of bladder cancer: Progress and challenges","volume":"44","author":"Warrick","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0020","series-title":"The Paris system for reporting urinary cytology","author":"Rosenthal","year":"2016"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0021","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0022-5347(06)00267-9","article-title":"Papillary urothelial neoplasm of low malignant potential: Evolving terminology and concepts","volume":"175","author":"Jones","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0022","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1464-410X.2003.04415.x","article-title":"Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential","volume":"92","author":"Fujii","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0023","doi-asserted-by":"crossref","first-page":"e83192","DOI":"10.1371\/journal.pone.0083192","article-title":"Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder","volume":"9","author":"Mangrud","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0024","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/jcp.55.12.900","article-title":"Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO\/ISUP classification system and comparison with conventional grading systems","volume":"55","author":"Oosterhuis","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.eururo.2017.04.015","volume":"72","author":"Soukup","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0026","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.eururo.2006.10.037","article-title":"Histologic grading of noninvasive papillary urothelial neoplasms","volume":"51","author":"MacLennan","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0027","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.eururo.2009.03.052","article-title":"Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications","volume":"57","author":"May","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0028","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.eururo.2016.12.008","article-title":"TERT promoter mutations occur frequently in urothelial papilloma and papillary urothelial neoplasm of low malignant potential","volume":"71","author":"Cheng","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0029","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/his.13441","article-title":"Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential","volume":"72","author":"Wang","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00428-017-2164-5","article-title":"Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder","volume":"471","author":"Rodriguez Pena","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0031","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cncr.20343","article-title":"Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder","volume":"101","author":"Cheng","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.12.007_bib0032","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.critrevonc.2013.08.008","article-title":"Biomarkers in bladder cancer: translational and clinical implications","volume":"89","author":"Cheng","year":"2014","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920306360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920306360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:20:01Z","timestamp":1761042001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920306360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1078143920306360"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.12.007","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}